Rephonic
Artwork for Flot.bio x Philip Hemme

Flot.bio x Philip Hemme

Flot.bio
Biotechnology
Ulcerative Colitis
EU Biotech
Biopharma
Abivax
Venture Capital
Syncore
Corvidia
Biotech
Novo Holdings
Clinical Trials
Biotech Industry
Gender Diversity
Immunotherapy
IPO
Novo
ALS
Gene Therapy
Cardior
Diversity In Biotech

Watch the #1 Biotech Podcast in Europe to grow. Hosted by Philip Hemme. 25k monthly views. Free. Guests include Antoine Papiernik @Sofinnova, Werner Lanthaler @Evotec, Ingmar Hoerr @CureVac, Bernat Olle @Vedanta, Johannes Fruehauf @BioLabs, Rodger Novak @CRISPR Tx, Agnete Fredriksen @Nykode, Mike Ward, Thomas Clozel @Owkin, Marc de Garidel @Abivax, Sander van Deventer @VectorY & Forbion, Jens Niel... more

PublishesWeeklyEpisodes53Founded3 years ago
Number of ListenersCategories
Life SciencesScience

Listen to this Podcast

Artwork for Flot.bio x Philip Hemme

Latest Episodes

Novonesis arose from a 2023 merger of Novozymes and Chr Hansen, and is a highly profitable powerhouse. CSO Claus talks about the applications of Novonesis’ technology, its low profile among consumers, and how hard it is for biosolutions startups to s... more

At the beginning of 2025, Sten R. Sörensen announced Cereno Scientific’s positive Phase 2a results in PAH for lead asset CS1. He’s now moving forward with a global Phase 2b trial starting in Q2 2026. The company also progresses its second HDACi asset... more

Founded in 1991, Camurus has grown into a $4B biotech with two products in the market, a rich pipeline, and 290 employees.Fredrik explains how Camurus’ long-acting injections — part of its FluidCrystal technology — breathe new life into generic drugs... more

Founded in 1979, Transgene has transformed itself into a leading personalized cancer vaccine player. Alessandro talks about the transformation, his history in cell therapy and how Europe’s biotech space can rival those of the US and China.

---

Lear... more

Key Facts

Accepts Guests
Accepts Sponsors
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

The Daily
The DailyThe New York Times

Recent Guests

Claus Crone Fuglsang
Chief Scientific Officer at Novonesis
Novonesis
Episode: Claus Crone Fuglsang, Novonesis 🇩🇰 | Biosolutions, Industrial biotech, Synbio | E53
Fredrik Tiberg
CEO of Camurus
Camurus
Episode: Fredrik Tiberg, Camurus 🇸🇪 | Opioid Crisis, Long-Acting Injections | E51
Alessandro Riva
CEO of Transgene
Transgene
Episode: Alessandro Riva, Transgene | Cancer Vaccines, Oncolytic Viruses | E50
Pascal Touchon
Veteran in cell therapy and an operating partner at Jeito.
Jeito
Episode: Pascal Touchon 🇫🇷 | Cell Therapy, Jeito, Kymriah | E49
Thomas Lingelbach
CEO of Valneva
Valneva
Episode: Thomas Lingelbach, Valneva | Vaccines, Lyme Disease | E47
Laurent Levy
Founder and CEO of Nanobiotix
Nanobiotix
Episode: Laurent Levy, Nanobiotix 🇫🇷 | Nanoparticles, Radiotherapy | E45
Fabrice Chouraqui
CEO of Pharming
Pharming
Episode: Fabrice Chouraqui, Pharming 🇳🇱 | Transgenic Rabbits, Rare Diseases | E43
Dragan Grabulovski
Founder of Araris and experienced entrepreneur in the biotech space.
Araris
Episode: Dragan Grabulovski, Araris 🇨🇭 | ADC Linkers, Replacing Chemotherapy | E41
Stefano Portolano
CEO of Azafaros, involved in developing treatments for rare lysosomal diseases.
Azafaros
Episode: Stefano Portolano, Azafaros 🇳🇱 🇨🇭 | Rare Diseases, Small Molecules | E40

Host

Philip Hemme
Host of Flot.bio; leads discussions on biotech, entrepreneurship, and industry trends.

Reviews

4.7 out of 5 stars from 27 ratings
  • One of the best video podcasts for Biotech

    I’m one of the founders so I’m a bit biased. But if it try to listen to it as a user, I find it to be one of the best video podcasts, especially with Europeans speakers and mostly for a European audience. Would love to hear what you think

    Apple Podcasts
    5
    phm12345
    Germany3 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Strong guest lineup with practical, market-focused discussions.
Relevant and deep insights into European biotech scene.
Concise, data-driven conversations that are valuable for sponsors and guests alike.
High-quality guests; sometimes heavy on industry jargon but valuable.
Great for follow-up pitches due to clear domain expertise and thoughtful questions.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

Claus Crone Fuglsang, Novonesis 🇩🇰 | Biosolutions, Industrial biotech, Synbio | E53
Q: So how come you have unique technology and unique positioning?
It boils down to having efficient production and keeping costs out of production while adding value, which is key for negotiations with customers.
Claus Crone Fuglsang, Novonesis 🇩🇰 | Biosolutions, Industrial biotech, Synbio | E53
Q: Do you feel Biosolutions is a neglected market compared to pharmaceuticals?
I think we are actually sensing a lot higher interest for biosolutions as a key enabler of a greener transition.
Sten R. Sörensen, Cereno Scientific 🇸🇪 | Drug Repurposing, Retail Investors | E52 [Sponsored]
Q: Why is repurposing generally viewed with skepticism from investors?
Historically, the pharmaceutical industry has favored new chemical entities over repurposed drugs due to concerns about patentability and market potential.
Sten R. Sörensen, Cereno Scientific 🇸🇪 | Drug Repurposing, Retail Investors | E52 [Sponsored]
Q: Can you talk a bit more about the data and the results?
The phase 2A study showed improvements in mortality risk and functional class for patients with pulmonary arterial hypertension.
Alessandro Riva, Transgene | Cancer Vaccines, Oncolytic Viruses | E50
Q: What's the most common misconceptions that investors have about cancer vaccines?
Investors often believe that cancer vaccines have never worked, but the current individualized approach is significantly different from past attempts.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Flot.bio x Philip Hemme

What is Flot.bio x Philip Hemme about and what kind of topics does it cover?

Across recent episodes, conversations skew biotech-forward: executives, researchers, and investors discuss breakthroughs in biotech, pharma, vaccines, and cell therapies, along with funding, regulation, and market strategy. Expect candid takes on industry challenges, European biotech dynamics, and the evolving business models driving biotech innovation, from AI-powered drug development to novel vaccine platforms and rare-disease therapies. Noteworthy traits include a strong European focus, a penchant for contrarian or forward-looking viewpoints, and an emphasis on practical path-to-market insights for startups and scaleups.

Where can I find podcast stats for Flot.bio x Philip Hemme?

Rephonic provides a wide range of podcast stats for Flot.bio x Philip Hemme. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Flot.bio x Philip Hemme and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Flot.bio x Philip Hemme get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Flot.bio x Philip Hemme, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Flot.bio x Philip Hemme?

Rephonic provides comprehensive predictive audience data for Flot.bio x Philip Hemme, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Flot.bio x Philip Hemme have?

To see how many followers or subscribers Flot.bio x Philip Hemme has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Flot.bio x Philip Hemme?

These podcasts share a similar audience with Flot.bio x Philip Hemme:

1. The Daily
2. Verden ifølge Gram

How many episodes of Flot.bio x Philip Hemme are there?

Flot.bio x Philip Hemme launched 3 years ago and published 53 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Flot.bio x Philip Hemme?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Flot.bio x Philip Hemme?

Rephonic pulls ratings and reviews for Flot.bio x Philip Hemme from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Flot.bio x Philip Hemme?

Rephonic provides full transcripts for episodes of Flot.bio x Philip Hemme. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Flot.bio x Philip Hemme?

Recent guests on Flot.bio x Philip Hemme include:

1. Claus Crone Fuglsang
2. Fredrik Tiberg
3. Alessandro Riva
4. Pascal Touchon
5. Thomas Lingelbach
6. Laurent Levy
7. Fabrice Chouraqui
8. Dragan Grabulovski

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days